Shenzhen YHLO Biotech Co., Ltd. (SHA:688575)
China
· Delayed Price · Currency is CNY 14.33
+0.34 (2.43%)
Apr 29, 2026, 3:00 PM CST
Shenzhen YHLO Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 8,188 | 8,114 | 9,010 | 12,993 | 11,142 | 13,993 | Upgrade
|
| Market Cap Growth | -11.04% | -9.95% | -30.65% | 16.62% | -20.38% | - | Upgrade
|
| Enterprise Value | 8,550 | 8,403 | 9,226 | 12,949 | 10,739 | 13,697 | Upgrade
|
| Last Close Price | 14.33 | 14.20 | 15.58 | 22.26 | 18.68 | 23.15 | Upgrade
|
| PE Ratio | 350.80 | 347.62 | 29.88 | 36.60 | 11.01 | 68.34 | Upgrade
|
| Forward PE | 23.40 | 21.63 | 16.84 | 27.31 | 17.99 | 34.64 | Upgrade
|
| PS Ratio | 4.52 | 4.48 | 4.48 | 6.33 | 2.80 | 11.88 | Upgrade
|
| PB Ratio | 3.05 | 3.02 | 3.34 | 5.13 | 4.56 | 9.24 | Upgrade
|
| P/TBV Ratio | 3.24 | 3.21 | 3.51 | 5.49 | 5.06 | 9.84 | Upgrade
|
| P/FCF Ratio | 130.78 | 129.60 | - | - | 10.95 | - | Upgrade
|
| P/OCF Ratio | 19.41 | 19.23 | 17.00 | - | 7.04 | 53.90 | Upgrade
|
| EV/Sales Ratio | 4.72 | 4.64 | 4.59 | 6.31 | 2.70 | 11.63 | Upgrade
|
| EV/EBITDA Ratio | 15.98 | 16.17 | 16.05 | 29.37 | 8.32 | 44.16 | Upgrade
|
| EV/EBIT Ratio | 36.92 | 36.29 | 27.50 | 51.46 | 9.37 | 64.96 | Upgrade
|
| EV/FCF Ratio | 136.57 | 134.22 | - | - | 10.55 | - | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.33 | 0.34 | 0.22 | 0.19 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 1.67 | 1.67 | 1.56 | 1.24 | 0.37 | 0.75 | Upgrade
|
| Debt / FCF Ratio | 14.31 | 14.31 | - | - | 0.47 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.14 | 0.14 | 0.07 | -0.06 | -0.39 | -0.17 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.72 | 0.72 | 0.33 | -0.35 | -0.74 | -0.84 | Upgrade
|
| Net Debt / FCF Ratio | 5.95 | 5.95 | -2.98 | 0.21 | -0.94 | 2.31 | Upgrade
|
| Asset Turnover | 0.42 | 0.42 | 0.49 | 0.51 | 1.25 | 0.68 | Upgrade
|
| Inventory Turnover | 1.00 | 1.00 | 1.10 | 1.58 | 4.15 | 1.60 | Upgrade
|
| Quick Ratio | 1.24 | 1.24 | 1.22 | 1.39 | 1.20 | 1.51 | Upgrade
|
| Current Ratio | 2.13 | 2.13 | 1.90 | 2.20 | 1.63 | 2.30 | Upgrade
|
| Return on Equity (ROE) | 2.54% | 2.54% | 10.40% | 11.22% | 51.59% | 17.89% | Upgrade
|
| Return on Assets (ROA) | 3.33% | 3.33% | 5.10% | 3.92% | 22.55% | 7.61% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.54% | 5.63% | 11.12% | 10.88% | 72.04% | 17.98% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.90% | 6.90% | 10.00% | 8.50% | 42.80% | 13.00% | Upgrade
|
| Earnings Yield | 0.29% | 0.29% | 3.35% | 2.73% | 9.08% | 1.46% | Upgrade
|
| FCF Yield | 0.76% | 0.77% | -0.70% | -5.66% | 9.13% | -0.81% | Upgrade
|
| Dividend Yield | 1.50% | - | 1.35% | 1.23% | 2.41% | 1.23% | Upgrade
|
| Payout Ratio | 606.57% | 606.57% | 56.06% | 79.58% | 16.70% | 5.32% | Upgrade
|
| Buyback Yield / Dilution | -2.56% | -2.41% | 0.49% | -0.70% | -5.53% | -6.03% | Upgrade
|
| Total Shareholder Return | -1.05% | -2.41% | 1.84% | 0.52% | -3.12% | -4.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.